NURS 6670 MIDTERM EXAM REVIEW
2026/2027 ACADEMIC CYCLE
100 QUESTIONS AND CORRECT ANSWERS
GRADED A+ | 100% VERIFIED | CERTAIN SUCCESS
Core Domains:
Neurobiology of Psychiatric Disorders | Psychopharmacology
Antidepressants | Antipsychotics | Mood Stabilizers | Anxiolytics | Stimulants
Anxiety Disorders (GAD, Panic, Social Anxiety, Phobias, OCD, PTSD)
Mood Disorders (MDD, Bipolar I & II, Persistent Depressive Disorder)
Psychotic Disorders (Schizophrenia, Schizoaffective, Delusional Disorder)
Personality Disorders (Cluster A, B, C)
Eating Disorders (Anorexia, Bulimia, Binge-Eating Disorder)
Substance Use Disorders & Addiction
Neurocognitive Disorders (Delirium, Dementia, Alzheimer's Disease)
Trauma & Stressor-Related Disorders
Somatic Symptom & Dissociative Disorders | Sleep-Wake Disorders
Suicide Risk Assessment & Prevention
Violence & Aggression Management
Psychiatric Emergency Management
Therapeutic Communication | Evidence-Based Psychotherapy Modalities
Cultural Considerations | Legal & Ethical Issues
Advanced Practice Psychiatric Nursing Role
Graduate-Level Nursing Focus
NURS 6670-Aligned Format | PMHNP Certification Preparation
,2026-2027 Academic Cycle
,INTRODUCTION
This NURS 6670 Psychiatric Disorders Midterm Exam Review for the 2026/2027 academic cycle reflects graduate-level
psychiatric mental health nursing curriculum standards for advanced practice nursing students. The examination evaluates
comprehensive understanding of psychiatric disorders, neurobiology, psychopharmacology, evidence-based
psychotherapies, and clinical judgment required for safe, competent advanced practice psychiatric nursing. Mastery of
psychiatric disorder content is essential for PMHNP certification and independent practice in psychiatric mental health
settings across the continuum of care.
Exam Structure
NURS 6670 Midterm Exam is structured as follows: 100 multiple-choice questions in single-best-answer format with
application-, analysis-, synthesis-, and clinical judgment-focused items. The examination includes integrated case-based
scenarios with psychiatric patients across the lifespan, questions incorporating advanced practice nursing frameworks,
select-all-that-apply (SATA) items as applicable, advanced psychopharmacology and medication management questions,
and comprehensive coverage of psychiatric disorders and treatment modalities.
Answer Format
All questions are presented in bold text for clear distinction and readability. All correct answers are presented in bold lime
green, followed by clearly defined, detailed, clinically focused rationales that reinforce evidence-based psychiatric nursing
practices, neurobiological understanding, psychopharmacologic reasoning, therapeutic interventions, and clinical judgment
required for optimal mental health outcomes in advanced practice nursing.
, NEUROBIOLOGY OF PSYCHIATRIC DISORDERS
1. Which neurotransmitter system is primarily implicated in the pathophysiology of schizophrenia?
A. Serotonin system
B. Dopamine system
C. Norepinephrine system
D. GABA system
Rationale: The dopamine hypothesis of schizophrenia suggests that excessive dopaminergic activity in the mesolimbic pathway
causes positive symptoms (hallucinations, delusions), while reduced dopamine in the mesocortical pathway contributes to negative
symptoms. Antipsychotics work primarily by blocking D2 receptors.
2. The monoamine hypothesis of depression suggests dysfunction in which neurotransmitters?
A. Dopamine and GABA
B. Serotonin, norepinephrine, and dopamine
C. Glutamate and GABA
D. Acetylcholine and histamine
Rationale: The monoamine hypothesis proposes that depression results from deficient monoamine neurotransmission involving
serotonin, norepinephrine, and dopamine. This theory supports the mechanism of antidepressants that increase synaptic availability of
these neurotransmitters.
PSYCHOPHARMACOLOGY
3. A patient on an SSRI reports sexual dysfunction. Which intervention is most appropriate?
A. Discontinue the medication immediately
B. Add bupropion to the regimen
C. Switch to an MAOI
D. Increase the SSRI dose
Rationale: Sexual dysfunction is a common SSRI side effect. Bupropion, a norepinephrine-dopamine reuptake inhibitor (NDRI), has
minimal sexual side effects and can be added to counteract SSRI-induced sexual dysfunction while providing adjunctive
antidepressant effect.
4. Which medication requires monitoring for agranulocytosis?
A. Risperidone
B. Olanzapine
C. Clozapine
D. Quetiapine
Rationale: Clozapine carries a black box warning for agranulocytosis, occurring in approximately 0.8% of patients. Weekly to
biweekly ANC monitoring is mandatory. Clozapine is reserved for treatment-resistant schizophrenia due to this risk but offers
superior efficacy.
5. What is the mechanism of action of selective serotonin reuptake inhibitors (SSRIs)?
A. Blocking serotonin reuptake at the presynaptic neuron
B. Increasing serotonin synthesis
C. Direct stimulation of serotonin receptors
D. Inhibiting monoamine oxidase